In a noteworthy development, federal health officials have revealed that Jeanne Marrazzo, the current director of infectious diseases in Alabama, will assume the position of head of the National Institute of Allergy and Infectious Diseases (NIAID) this fall. This announcement comes approximately eight months after Anthony Fauci, the former NIAID Director, stepped down following his extensive 40-year tenure. Marrazzo presently serves as the director of the Division of Infectious Diseases at the University of Alabama at Birmingham.
Marrazzo will commence her role overseeing the $6.3 billion agency precisely as Congress delves into the 2024 budget. It is worth noting that some Republicans are considering substantial funding cuts across various sectors. NIAID provides research support to universities, as well as research organizations nationwide and within its own 21 laboratories.
Similar to her predecessor Fauci, Marrazzo boasts considerable expertise in HIV research, specifically in the realm of sexually transmitted diseases, female reproductive tract infections, and hormonal contraception.
Acting NIH Director Lawrence Tabak stated, “Dr. Marrazzo brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organizational budget that includes research funding and mentoring trainees in all stages of professional development.”
Unlike Monica Bertagnolli, Tabak’s permanent replacement, Marrazzo will not require Senate confirmation. Bertagnolli’s nomination remains in limbo due to the Senate’s health committee chairman Bernie Sanders’ refusal to hold a hearing until the White House commits to taking stronger action to lower drug prices.
In line with its mission to address emerging and recurring public health threats domestically and internationally, NIAID’s research efforts pertaining to diseases such as HIV, Ebola, and COVID-19 have yielded novel therapies, vaccines, diagnostic tests, and other technological advancements.
Considering the scrutiny surrounding NIAID funding for high-risk pathogen research, Marrazzo can expect inquiries from Republican members of the House and Senate during the ongoing investigation into the origins of the COVID-19 pandemic.
© 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
